Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children.
about
Schistosomiasis Prevalence and Intensity of Infection in Latin America and the Caribbean Countries, 1942-2014: A Systematic Review in the Context of a Regional Elimination GoalSchistosomiasis-associated pulmonary hypertensionNovel therapeutic and prevention approaches for schistosomiasis: reviewEfficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobiumPerformance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool childrenNew insights into the molecular epidemiology and population genetics of Schistosoma mansoni in Ugandan pre-school children and mothersPutting the treatment of paediatric schistosomiasis into context.Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies.The Lake Victoria Island Intervention Study on Worms and Allergy-related diseases (LaVIISWA): study protocol for a randomised controlled trial.Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trialHuman schistosomiasisSchistosomiasis in pre-school-age children and their mothers in Chikhwawa district, Malawi with notes on characterization of schistosomes and snails.The urine circulating cathodic antigen (CCA) dipstick: a valid substitute for microscopy for mapping and point-of-care diagnosis of intestinal schistosomiasis.Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmesFrom a weighing scale to a pole: a comparison of two different dosage strategies in mass treatment of Schistosomiasis haematobium.Immunology of human schistosomiasis.Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children.Group 2 innate lymphoid cell proportions are diminished in young helminth infected children and restored by curative anti-helminthic treatment.Morbidity associated with schistosomiasis before and after treatment in young children in Rusinga Island, western Kenya.Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose poleUse of fecal occult blood tests as epidemiologic indicators of morbidity associated with intestinal schistosomiasis during preventive chemotherapy in young children.Schistosoma mansoni infection in preschool-aged children: development of immunoglobulin E and immunoglobulin G4 responses to parasite allergen-like proteins.Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection.Epidemiology of schistosomiasis in two high-risk communities of south Cote d'Ivoire with particular emphasis on pre-school-aged childrenFecal occult blood and fecal calprotectin as point-of-care markers of intestinal morbidity in Ugandan children with Schistosoma mansoni infection.Schistosomiasis in African infants and preschool children: let them now be treated!Schistosomiasis in infants and pre-school-aged children in sub-Saharan Africa: implication for control.Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis.Urinary schistosomiasis.A centenary of Robert T. Leiper's lasting legacy on schistosomiasis and a COUNTDOWN on control of neglected tropical diseases.Global trends in neglected tropical disease control and elimination: impact on child health.One hundred years of neglect in paediatric schistosomiasis.Schistosomiasis Sustained Control Program in Ethnic Groups Around Ninefescha (Eastern Senegal).Paediatric and maternal schistosomiasis: shifting the paradigms.Developing a comprehensive response for treatment of children under 6 years of age with schistosomiasis: research and development of a pediatric formulation of praziquantel.Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children.Outbreak of Philophthalmus gralli in four greater rheas (Rhea americana).Progress in paediatric parasitology: a preface to a topic focusing on ever younger subjects.Organomegaly in Mali before and after praziquantel treatment. A possible association with Schistosoma haematobium.Dynamics of paediatric urogenital schistosome infection, morbidity and treatment: a longitudinal study among preschool children in Zimbabwe.
P2860
Q26752354-BC78DBAD-2F17-4EAE-89CA-F4982BCB9488Q27006491-E65C0535-4E80-49BB-ACD4-CBD3747C5CC1Q27008897-3436CAF9-7DE3-4B55-9BF0-06F1CF926234Q28484235-947E678F-5E6E-4E34-8CEB-0BA1D810C950Q28484474-25881CDB-B6C1-4B96-B2CF-1D825BEA6AB2Q28537580-5AC4D557-1261-4BAD-96E6-1C5DF99ECF72Q30234902-6E31F1E4-DC5F-44EB-9588-7FACDEDDA367Q30378695-027E2E77-6A8E-4A7A-A624-1549B60EA225Q30645103-7D7B9731-A3CB-4905-A98A-7E7844818F6AQ33800953-861BA5E6-9320-46F3-AB50-CC4A8877F062Q34413522-0569B277-6674-44A8-8158-BFC42B668DAEQ34502188-E3B6C02B-8BC2-48B7-8C56-3756C3708387Q34566624-65D72AA0-89DE-4AD5-9F77-90F85484F64CQ34629346-74706448-3118-4785-BE96-F25EC232A221Q34635112-92E43246-7A3B-4D90-810E-29421CDBFB01Q34782228-E43FF960-7BDA-43AB-BF86-F1225C2D63D8Q35202035-2F3DB531-21DD-45F9-8043-D5D6A91558ECQ35208931-E0490A6B-52DA-4369-97DD-A0C4FF7D7826Q35590782-A85EDDCA-F123-42CE-ACEE-B75D581BCD04Q36125948-FFC6F4A3-1C04-43F9-9FAD-AF738F66A7B0Q36450832-70AF1DC3-5224-487E-B6E0-916D775200FAQ36495600-93CB29F3-C3DA-4666-98CE-30ECC6EA7F84Q36942712-8C6F39D1-3338-4A14-8FFC-7700B446CF47Q37107975-9B7B0287-7E15-4E01-ACAA-C888DE614684Q37308686-09A12E29-416B-4D61-8138-C24FFAC806DCQ37427116-FAB6078A-FFC9-4B6F-AAA2-624FBB44FB00Q37982161-CF80B396-99B4-4F7C-9F79-15223792B750Q38123553-FFB3D4D4-4B4F-4F7E-824A-EC8415998360Q38182412-8B2E58B8-3A55-45E9-B03D-75BFAFEF9E2EQ38854033-BA5BC7BF-EA4D-4B99-AFAC-433B278779DDQ38894845-15DFB542-B191-4F94-B72C-607F395684ACQ38927082-9427E01B-3FF9-40BB-AA45-6DB68B2F882CQ39288169-C1875422-F809-4433-AA93-27EC1B64AF45Q40045772-B03C18C1-3A80-45BB-A255-4DC75C147E95Q40109665-58ED6B80-310E-40B3-858D-9EB275ADD043Q40539438-6074D799-1CEE-4213-BD27-A36A15348DDFQ44128438-690C9CDC-204A-4D79-BF98-CA744ACF8700Q46326563-58C9CF1D-4D0A-4A30-92DF-8CFB8062F788Q47155280-73FBC97F-37B5-4C3F-91D9-304CF5987A7EQ52608449-52598B1C-78C7-46E3-BD95-A1C656A0D8C5
P2860
Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Closing the praziquantel treat ...... s and preschool-aged children.
@ast
Closing the praziquantel treat ...... s and preschool-aged children.
@en
Closing the praziquantel treat ...... s and preschool-aged children.
@nl
type
label
Closing the praziquantel treat ...... s and preschool-aged children.
@ast
Closing the praziquantel treat ...... s and preschool-aged children.
@en
Closing the praziquantel treat ...... s and preschool-aged children.
@nl
prefLabel
Closing the praziquantel treat ...... s and preschool-aged children.
@ast
Closing the praziquantel treat ...... s and preschool-aged children.
@en
Closing the praziquantel treat ...... s and preschool-aged children.
@nl
P2093
P2860
P50
P921
P1433
P1476
Closing the praziquantel treat ...... s and preschool-aged children.
@en
P2093
Albis F Gabrielli
Amadou Garba
Annalan Navaratnam
Edmund Y W Seto
Helen K Green
J Russell Stothard
José C Sousa-Figueiredo
Margaret Mutumba-Nakalembe
Moussa Sacko
Mutamad A Amin
P2860
P304
P356
10.1017/S0031182011001235
P5008
P577
2011-08-24T00:00:00Z
2011-10-01T00:00:00Z